Pictet Asset Management (UK)’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-5,860
Closed -$1.55M 872
2014
Q1
$1.55M Sell
5,860
-2,707
-32% -$717K 0.01% 759
2013
Q4
$3.11M Buy
8,567
+5,320
+164% +$1.93M 0.02% 642
2013
Q3
$1.73M Buy
+3,247
New +$1.73M 0.01% 746